Grown Rogue International (GRUSF) Gross Profit (2011 - 2026)
Grown Rogue International's (GRUSF) quarterly Gross Profit came in at $4.0 million in Q1 2026, up 17.66% year-on-year from $3.4 million in Q1 2025, and up 100.0% quarter-over-quarter from -$8141.4 billion in Q4 2025.
Grown Rogue International (GRUSF) Gross Profit (2011 - 2026) Analysis & Trends
Grown Rogue International's Gross Profit history runs 13 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- On a quarterly basis, Gross Profit rose 17.66% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $2301485442.0 billion, a 10484553494263.06% increase from a year earlier, with the FY2025 full-year figure at $14.1 million, up 6.82% from the prior year.
- Gross Profit improved to $4.0 million in Q1 2026 per GRUSF's latest filing, from -$8141.4 billion in the prior quarter.
- Across five years, Gross Profit topped out at $2301490000.0 billion in Q2 2025 and bottomed at -$8141.4 billion in Q4 2025.
- The 5-year median for Gross Profit is $3.3 million (2024), against an average of $153432362.8 billion.
- Biggest YoY gain for Gross Profit was 93252025519628.6% in 2025; the steepest drop was 61477219.0% in 2025.
- Year by year, Gross Profit stood at $2.3 million in 2022, then gained by 2.51% to $2.4 million in 2023, then soared by 458.59% to $13.2 million in 2024, then sank by 61477219.0% to -$8141.4 billion in 2025, then jumped by 100.0% to $4.0 million in 2026.
- Per Business Quant, the three latest GRUSF Gross Profit figures stand at $4.0 million (Q1 2026), -$8141.4 billion (Q4 2025), and $3583.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Mn |
| Mar 31, 2026 | 3.96 Mn |
| Dec 31, 2025 | -8,141.39 Bn |
| Dec 31, 2025 | -8,141.39 Bn |
| Sep 30, 2025 | 3,583.38 Bn |
| Sep 30, 2025 | 3,583.38 Bn |
| Jun 30, 2025 | 2,301,490,000.00 Bn |
| Jun 30, 2025 | 2,301,490,000.00 Bn |
| Mar 31, 2025 | 3.36 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Dec 31, 2023 | 2.37 Mn |